LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
37.83
-3.08 (-7.53%)
At close: Aug 15, 2025, 3:59 PM
39.27
3.81%
After-hours: Aug 15, 2025, 07:32 PM EDT

LENZ Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
37.61M 23.04M 20.16M 41.05M 84.15M 200.36M 185.86M 182.99M 128.51M 69.81M 47.73M 56.39M 75.17M 185.07M 376.98M 394.95M 382.11M 177.16M
Short-Term Investments
171.91M 170.93M 188.87M 176.06M 112.08M 12.92M 30.65M 51M 118.16M 194.28M 220.5M 235.29M 247.12M 154.11M n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a 1.72M 1.72M 1.72M 17.04M 15.12M 7.7M 14.64M n/a n/a n/a n/a
Other Long-Term Assets
1.6M 1.4M 1.4M 1.4M 1.4M 21K 2.76M n/a 355K 889K 1.29M 844K 335K 711K 2.17M 12K 11K 728K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
4.08M 3.88M 114K 114K 3.24M 3.4M 1.45M 20K 1.63M n/a 2.2M n/a 4.35M 4.57M 4.76M 6.28M 2.64M 3.1M
Total Current Assets
213.6M 197.86M 211.92M 220.7M 199.35M 216.67M 188.02M 238.78M 251.17M 270.31M 275.37M 298.49M 326.64M 343.76M 381.74M 401.23M 384.75M 180.27M
Property-Plant & Equipment
2.13M 2M 1.99M 1.91M 1.89M 627K 321K 25.73M 33.8M 37.08M 28.21M 20.39M 19.1M 19.5M 18.08M 14.91M 2.34M 1.92M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
3.73M 3.39M 3.39M 3.3M 3.29M 648K 3.13M 27.45M 35.87M 39.69M 46.54M 36.35M 27.14M 34.85M 20.25M 14.92M 2.35M 2.65M
Total Assets
217.33M 201.25M 215.3M 224.01M 202.64M 217.32M 188.46M 266.23M 287.04M 310M 321.9M 334.85M 353.79M 378.61M 401.99M 416.15M 387.11M 182.91M
Account Payables
2.85M 3.66M 4.26M 2.76M 4.41M 7.13M 250K 3.71M 2.72M 1.99M 2.26M 3.97M 3.62M 3.07M 2.45M 1.76M 4.05M 1.61M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a 649K 433K 285K n/a 2.91M 3.12M n/a 4.56M 4.93M 5.64M n/a 4.81M n/a n/a
Other Current Liabilities
n/a n/a 2.02M n/a 1.98M n/a 2.73M -2.87M 3.93M 5.76M 6.04M 1.65M 1.34M 4.06M 7M 3.04M 3.81M 4.5M
Total Current Liabilities
10.4M 8.57M 10.41M 7.71M 8.58M 18.89M 4.8M 12.54M 12.27M 14.34M 13.04M 13.52M 12.07M 12.77M 12.14M 11.27M 7.86M 6.39M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 64K 83K 111K n/a 49.45M n/a 18.01M 12.42M 2.42M n/a n/a n/a 64K 64K 64K
Total Long-Term Liabilities
569K 673K 814K 1.02M 1.14M 267K 77K 49.67M 50.63M 19.43M 12.57M 4.87M 3.26M 4.54M n/a 4.75M 64K 64K
Total Liabilities
10.97M 9.24M 11.22M 8.73M 9.72M 19.16M 4.87M 62.21M 62.9M 33.77M 25.61M 18.39M 15.33M 17.31M 12.14M 16.02M 7.92M 6.46M
Total Debt
1.05M 1.18M 1.38M 1.58M 1.7M 589K 362K 53.11M 53.54M 4.54M 5.79M 7.01M 8.19M 10.18M n/a 9.49M n/a n/a
Common Stock
1K 1K 1K n/a n/a n/a 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K n/a
Retained Earnings
-174.54M -159.63M -145.01M -132.36M -62K -111.89M -367.05M -344.14M -321.65M -266.34M -242.4M -217.8M -193.12M -167.19M -141.35M -122.42M -107.83M -90.3M
Comprehensive Income
38K 123K 196K 523K -62K -1K 6K -95K -271K -469K -1.05M -1.6M -1.03M -309K -999 n/a n/a n/a
Shareholders Equity
206.37M 192.01M 204.08M 215.28M 192.92M 198.17M 183.58M 204.02M 224.15M 276.22M 296.29M 316.45M 338.46M 361.3M 389.84M 400.13M 379.18M 176.46M
Total Investments
171.91M 170.93M 188.87M 176.06M 112.08M 12.92M 30.65M 52.71M 119.88M 196M 237.54M 250.41M 254.82M 168.75M n/a n/a n/a n/a